Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure
A TauRx Therapeutics drug designed to dissolve tangles of a protein called tau in the brain failed to slow cognitive and functional declines of Alzheimer's patients compared with a control.
With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'
Retrophin (RTRX), the biotech company that used to be run by indicted hedge fund manager Martin Shkreki, provides an interesting investment opportunity.
Despite Shkreli drama, Retrophin looks interesting now
One biotech portfolio manager thinks Retrophin, the biotech company once run by indicted hedge fund manager Martin Shkreli, could be a promising investment.
SAC Capital Pleads Guilty to Decade-Long Insider Trading Conspiracy
SAC Capital will pay $1.8 billion and plead guilty to a handful of criminal charges, as trader prosecutions loom.
Cramer's 6 Stocks in 60 Seconds: PRGO CREE HOG GME ORCL MHK (Update 1)
Cramer remains bullish on Cree and thinks Harley-Davidson will continue riding to profit,
The Arena Group Q2 Gross Profit Nearly Doubles; Revenue Up 87%
The Arena Group, publisher of Sports Illustrated, TheStreet, Parade and more, reported that Q2 gross profit, revenue and digital-ad revenue jumped.
Will JetBlue Take Away the One Thing People Like About Spirit?
The takeover of the budget airline raises a key question for consumers.
Micron and Nvidia: Buy or Sell After Bearish Updates?
Nvidia provided negative news on Monday and Micron followed up with more on Tuesday. Here's the trade.
Walmart Builds on Its Biggest Edge Over Amazon
Retailing giant Walmart wants to ensure its customers can get what they're looking for, however they want to buy it.